[Correction of affective disorders in patients with cochlear-vestibular disturbances of vascular origin].
N L
NL
Kunel'skaia
Kh Ia
KhIa
Umarova
A E
AE
Gulieva
A V
AV
Chugunov
P R
PR
Kamchatnov
D000328:Adult; D000368:Aged; D000700:Analgesics; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use*; D001299:Audiometry / Q000379:methods; D015834:Cochlear Diseases / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D003511:Cyclohexanols / Q000008:administration & dosage / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D019964:Mood Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D011594:Psychometrics / Q000379:methods; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D017585:Ultrasonography, Doppler, Transcranial / Q000379:methods; D000069470:Venlafaxine Hydrochloride; D015837:Vestibular Diseases / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology
D000700:Analgesics; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride